Drug Recalls Archives - Page 16 of 45

Top 5 Thing to Know Before Filing a Defective Drug Lawsuit

August 10, 2016 By Davis Alley Leave a Comment

Taking a defective drug can have serious side effects that can make you sick – sometimes sicker than the disease or condition it was prescribed to treat. The consequences of taking it could lead to hospitalization and, in some cases, even death. If you or a loved one has experienced the effects of taking a dangerous drug, you should seek help from … [Read more...]

FDA Strengthens Warning of Kidney Damage on Diabetes Drugs

August 5, 2016 By Sandra Dalton Leave a Comment

Newer Type 2 diabetes drugs, called sodium-glucose co-transporter 2 (SGLT2) inhibitors, hit the market in March, 2013. Invokana (canagliflozin) was the first to receive approval from the U.S. Food and Drug Administration (FDA). Since then SGLT2 inhibitors have been linked to serious side effects, including kidney damage. Now, based on recent … [Read more...]

Xarelto Bellwether Cases Selected

July 27, 2016 By Sandra Dalton Leave a Comment

Xarelto multidistrict litigation (MDL) 2592 consolidates more than 2,800 lawsuits against Bayer AG and Janssen Pharmaceuticals. 40 bellwether cases have been selected in the MDL. The bellwether cases are meant to be representative of everything that will be covered in the individual cases. MDL is different from a class action in that the individual … [Read more...]

Taxotere Hair Loss Claims

July 20, 2016 By US Recall News Leave a Comment

If you are living with permanent hair loss (alopecia) after chemotherapy for breast cancer, Taxotere (docetaxel) may be to blame. Lawsuits allege that Taxotere maker Sanofi-Aventis knew that its drug carried the risk of causing permanent hair loss, but chose not to warn doctors or patients, in the U.S., about the danger, even while it was warning … [Read more...]

Abilify Linked to Compulsive Gambling and Other Impulse-Control Problems

July 5, 2016 By Sandra Dalton Leave a Comment

Abilify (aripiprazole) is an atypical antipsychotic that was approved by the U.S. Food and Drug Administration (FDA) in 2002 to treat schizophrenia. Over the years, it was approved to treat more conditions, including depression and bipolar disorder. In May, 2016, the FDA issued a safety warning announcing that the drug was associated with … [Read more...]